About LaCell
LaCell is a company based in New Orleans (United States) founded in 2010. LaCell operates in a competitive market with competitors including BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and ArunA Bio, among others.
- Headquarter New Orleans, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$225 K (USD), Grant
Jul 01, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of LaCell
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $225,000
-
First Round
First Round
(01 Aug 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Grant - LaCell | Valuation |
investors |
|
| Aug, 2012 | Amount | Grant - LaCell | Valuation |
investors |
Investors in LaCell
LaCell has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LaCell
Financial Statements - LaCell
Lacell Comparisons
Competitors of LaCell
LaCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and ArunA Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| domain | founded_year | HQ Location |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
|
| domain | founded_year | HQ Location |
Transfection Solutions for Healthcare and Life Sciences organizations
|
|
| domain | founded_year | HQ Location |
Neural exosome platform is developed for neurodegenerative disease therapeutics.
|
|
| domain | founded_year | HQ Location |
Veterinary diagnostics products are developed for bovine viral diarrhea testing.
|
Latest news on Lacell
Frequently Asked Questions about LaCell
LaCell was founded in 2010 and raised its 1st funding round 2 years after it was founded.
LaCell is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
LaCell focuses on the production of stem cells for scientific investigators in the academic and biotechnology research community. The company plans to facilitate to clinical translation and regulatory approval of stem cells as regenerative therapies. Its product portfolio includes human adult stem cell, murine stem cell, and medium saline reagents.
LaCell's top competitors include FabricNano, RoosterBio and BioLife Solutions.
LaCell has 2 investors. Key investors include HHS, and National Science Foundation.